Jubilant Pharmova
- Advice
- Hold
Jubilant Pharmova Performance
Day Range
- Low 409.4
- High 436
52 Week Range
- Low 268.9
- High 485.1
- Open Price419.85
- Previous Close420.75
- Volume417372
Start SIP in Jubilant Pharmova
Start SIPJubilant Pharmova Investment Rating
-
Master Rating:
-
Jubilant Pharmova has an operating revenue of Rs. 6,497.71 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 0% needs improvement, ROE of -1% is poor and needs improvement. The company has a debt to equity of 58%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 12% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 38 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 186 | 204 | 189 | 183 | 215 | 200 | 29 |
Operating Expenses Qtr Cr | 186 | 213 | 198 | 185 | 216 | 209 | 30 |
Operating Profit Qtr Cr | 1 | 4 | 2 | -2 | 7 | -4 | -2 |
Depreciation Qtr Cr | 12 | 11 | 11 | 12 | 11 | 9 | 2 |
Interest Qtr Cr | 7 | 6 | 6 | 6 | 4 | 3 | 8 |
Tax Qtr Cr | 1 | 0 | 30 | -5 | 6 | -1 | -1 |
Net Profit Qtr Cr | 0 | 2 | -31 | -6 | 92 | -5 | -3 |
Jubilant Pharmova Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹414.85
- 50 Day
- ₹412.37
- 100 Day
- ₹405.83
- 200 Day
- ₹393.74
- 20 Day
- ₹409.68
- 50 Day
- ₹412.02
- 100 Day
- ₹414.53
- 200 Day
- ₹371.85
Jubilant Pharmova Resistance and Support
Resistance | |
---|---|
First Resistance | ₹442.6 |
Second Resistance | ₹452.6 |
Third Resistance | ₹469.2 |
RSI | 60.3 |
MFI | 72.12 |
MACD Single Line | 3.88 |
MACD | 6.42 |
Support | |
---|---|
First Resistance | ₹416 |
Second Resistance | ₹399.4 |
Third Resistance | ₹389.4 |
Jubilant Pharmova Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 462,621 | 24,662,326 | 53.31 |
Week | 275,295 | 16,649,811 | 60.48 |
1 Month | 451,144 | 21,388,751 | 47.41 |
6 Month | 354,802 | 13,237,665 | 37.31 |
Jubilant Pharmova Result Highlights
Jubilant Pharmova Synopsis
NSE-Medical-Diversified
Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 810.12 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2023. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.Market Cap | 6,839 |
Sales | 786 |
Shares in Float | 7.80 |
No of funds | 152 |
Yield | 1.2 |
Book Value | 2.76 |
U/D Vol ratio | 1.5 |
LTDebt / Equity | 7 |
Alpha | 0.02 |
Beta | 1.29 |
Jubilant Pharmova
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 50.68% | 50.68% | 50.68% | 50.68% |
Mutual Funds | 0.42% | 0.41% | 0.4% | 0.4% |
Foreign Portfolio Investors | 23.2% | 23.2% | 23.22% | 23.38% |
Financial Institutions/ Banks | ||||
Individual Investors | 18.24% | 18.25% | 18.69% | 18.68% |
Others | 7.46% | 7.46% | 7.01% | 6.86% |
Jubilant Pharmova Management
Name | Designation |
---|---|
Mr. Shyam S Bhartia | Chairman |
Mr. Hari S Bhartia | Co-Chairman |
Mr. Priyavrat Bhartia | Managing Director |
Mr. Arjun Shanker Bhartia | Joint Managing Director |
Mr. Arvind Chokhany | WholeTime Director & Group CFO |
Mr. R Kumar | Whole Time Director |
Mr. Vivek Mehra | Independent Director |
Mr. Sushil Kumar Roongta | Independent Director |
Mr. Arun Seth | Independent Director |
Ms. Sudha Pillai | Independent Director |
Dr. Ashok Misra | Independent Director |
Mr. S Sridhar | Independent Director |
Mr. Shirish G Belapure | Independent Director |
Jubilant Pharmova Forecast
Price Estimates
Jubilant Pharmova Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-10-27 | Quarterly Results | |
2023-07-19 | Quarterly Results | |
2023-05-29 | Audited Results & Final Dividend | |
2023-02-03 | Quarterly Results | |
2022-10-21 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-08-10 | FINAL | Rs.5.00 per share(500%)Final Dividend |
2022-08-12 | FINAL | Rs.5.00 per share(500%)Final Dividend |
2021-08-06 | FINAL | Rs.5.00 per share(500%)Final Dividend |
Jubilant Pharmova FAQs
What is Share Price of Jubilant Pharmova ?
Jubilant Pharmova share price is ₹432 As on 28 November, 2023 | 22:09
What is the Market Cap of Jubilant Pharmova ?
The Market Cap of Jubilant Pharmova is ₹6890.5 Cr As on 28 November, 2023 | 22:09
What is the P/E ratio of Jubilant Pharmova ?
The P/E ratio of Jubilant Pharmova is -154.5 As on 28 November, 2023 | 22:09
What is the PB ratio of Jubilant Pharmova ?
The PB ratio of Jubilant Pharmova is 1.3 As on 28 November, 2023 | 22:09